JP2005538151A - 尿素−、グリセラート−及びヒドロキシアミド−頭部形成した炭化水素鎖のリオトロピック相形成性界面活性剤 - Google Patents
尿素−、グリセラート−及びヒドロキシアミド−頭部形成した炭化水素鎖のリオトロピック相形成性界面活性剤 Download PDFInfo
- Publication number
- JP2005538151A JP2005538151A JP2004533054A JP2004533054A JP2005538151A JP 2005538151 A JP2005538151 A JP 2005538151A JP 2004533054 A JP2004533054 A JP 2004533054A JP 2004533054 A JP2004533054 A JP 2004533054A JP 2005538151 A JP2005538151 A JP 2005538151A
- Authority
- JP
- Japan
- Prior art keywords
- phase
- surfactant
- integer
- group
- lyotropic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000004094 surface-active agent Substances 0.000 title claims abstract description 122
- 230000002535 lyotropic effect Effects 0.000 title claims abstract description 90
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title abstract description 10
- 125000001183 hydrocarbyl group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 36
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 10
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 5
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 111
- 230000002441 reversible effect Effects 0.000 claims description 102
- 239000000203 mixture Substances 0.000 claims description 38
- 239000000693 micelle Substances 0.000 claims description 26
- 239000002245 particle Substances 0.000 claims description 24
- 239000004973 liquid crystal related substance Substances 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 20
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 16
- 239000002360 explosive Substances 0.000 claims description 8
- 238000000576 coating method Methods 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- -1 octadec-9-enyl Chemical group 0.000 claims description 5
- 238000006116 polymerization reaction Methods 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000005065 mining Methods 0.000 claims description 4
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 4
- 238000005191 phase separation Methods 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 3
- YFHFHLSMISYUAQ-UHFFFAOYSA-N farnesane Chemical compound CCC(C)CCCC(C)CCCC(C)C YFHFHLSMISYUAQ-UHFFFAOYSA-N 0.000 claims description 3
- 230000005855 radiation Effects 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 108091034117 Oligonucleotide Proteins 0.000 claims description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 238000005237 degreasing agent Methods 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- 229940039227 diagnostic agent Drugs 0.000 claims description 2
- 239000000032 diagnostic agent Substances 0.000 claims description 2
- 239000003337 fertilizer Substances 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 239000000178 monomer Substances 0.000 claims description 2
- 239000000575 pesticide Substances 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000003505 polymerization initiator Substances 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 230000008439 repair process Effects 0.000 claims description 2
- 208000017520 skin disease Diseases 0.000 claims description 2
- 230000000475 sunscreen effect Effects 0.000 claims description 2
- 239000000516 sunscreening agent Substances 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 230000029663 wound healing Effects 0.000 claims description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 claims 4
- 230000002496 gastric effect Effects 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- 239000003961 penetration enhancing agent Substances 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 20
- 239000004202 carbamide Substances 0.000 abstract description 9
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 abstract description 4
- 239000002798 polar solvent Substances 0.000 abstract description 2
- 239000012071 phase Substances 0.000 description 248
- 238000000034 method Methods 0.000 description 29
- 239000000463 material Substances 0.000 description 22
- 239000006185 dispersion Substances 0.000 description 20
- 230000008018 melting Effects 0.000 description 16
- 238000002844 melting Methods 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- 230000002209 hydrophobic effect Effects 0.000 description 15
- 230000008569 process Effects 0.000 description 15
- 239000007787 solid Substances 0.000 description 15
- 238000005481 NMR spectroscopy Methods 0.000 description 13
- 239000007864 aqueous solution Substances 0.000 description 13
- 230000000704 physical effect Effects 0.000 description 13
- 238000010790 dilution Methods 0.000 description 12
- 239000012895 dilution Substances 0.000 description 12
- 238000005160 1H NMR spectroscopy Methods 0.000 description 11
- 230000008859 change Effects 0.000 description 11
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 11
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 10
- 239000002904 solvent Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000008346 aqueous phase Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000000921 elemental analysis Methods 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 0 CC(C)CCCC(C)CCCC(C)CCCC(C)CC*C(NCCO)=O Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)CC*C(NCCO)=O 0.000 description 5
- 229910002056 binary alloy Inorganic materials 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 3
- 241000446313 Lamella Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000003752 hydrotrope Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229940074096 monoolein Drugs 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 239000011111 cardboard Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001246 colloidal dispersion Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 150000002314 glycerols Chemical class 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- RLCKHJSFHOZMDR-UHFFFAOYSA-N phytanic acid Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)CC(O)=O RLCKHJSFHOZMDR-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000000235 small-angle X-ray scattering Methods 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- ZVIYLDBXOQNRHA-KTKRTIGZSA-N 1-(2-hydroxyethyl)-3-[(z)-octadec-9-enyl]urea Chemical compound CCCCCCCC\C=C/CCCCCCCCNC(=O)NCCO ZVIYLDBXOQNRHA-KTKRTIGZSA-N 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- ZWGOKSXVMODEMQ-UHFFFAOYSA-N 3,7,11,15-tetramethylhexadecyl 2,3-dihydroxypropanoate Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)CCOC(=O)C(O)CO ZWGOKSXVMODEMQ-UHFFFAOYSA-N 0.000 description 1
- AGCFNJDUTAYVDQ-UHFFFAOYSA-N 3,7,11,15-tetramethylhexadecylurea Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)CCNC(N)=O AGCFNJDUTAYVDQ-UHFFFAOYSA-N 0.000 description 1
- HDPUXESLSOZSIB-UHFFFAOYSA-N 3,7,11-trimethyldodecan-1-ol Chemical compound CC(C)CCCC(C)CCCC(C)CCO HDPUXESLSOZSIB-UHFFFAOYSA-N 0.000 description 1
- HAOQHOCIIVTYRX-UHFFFAOYSA-N 3,7,11-trimethyldodecylurea Chemical compound CC(C)CCCC(C)CCCC(C)CCNC(N)=O HAOQHOCIIVTYRX-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- LEQSIQZVXHNUJJ-UHFFFAOYSA-N C(CC(C)CCCC(C)CCCC(C)CCCC(C)C)O.CCCCCCCCCCCCCCCC Chemical compound C(CC(C)CCCC(C)CCCC(C)CCCC(C)C)O.CCCCCCCCCCCCCCCC LEQSIQZVXHNUJJ-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 239000004169 Hydrogenated Poly-1-Decene Substances 0.000 description 1
- 238000012695 Interfacial polymerization Methods 0.000 description 1
- 238000003109 Karl Fischer titration Methods 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 206010058667 Oral toxicity Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000004974 Thermotropic liquid crystal Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000007798 antifreeze agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000003012 bilayer membrane Substances 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000005388 cross polarization Methods 0.000 description 1
- 238000000604 cryogenic transmission electron microscopy Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 235000019383 crystalline wax Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000013538 functional additive Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 125000005645 linoleyl group Chemical group 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- JPJYKWFFJCWMPK-UHFFFAOYSA-N octadec-9-enyl 2,3-dihydroxypropanoate Chemical compound CCCCCCCCC=CCCCCCCCCOC(=O)C(O)CO JPJYKWFFJCWMPK-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 231100000418 oral toxicity Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000016046 other dairy product Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000011087 paperboard Substances 0.000 description 1
- 238000003921 particle size analysis Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000005501 phase interface Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- CGIHFIDULQUVJG-UHFFFAOYSA-N phytantriol Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)(O)C(O)CO CGIHFIDULQUVJG-UHFFFAOYSA-N 0.000 description 1
- CGIHFIDULQUVJG-VNTMZGSJSA-N phytantriol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(O)[C@H](O)CO CGIHFIDULQUVJG-VNTMZGSJSA-N 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000004781 supercooling Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 239000002691 unilamellar liposome Substances 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/10—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
- C07C275/58—Y being a hetero atom
- C07C275/62—Y being a nitrogen atom, e.g. biuret
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002951216A AU2002951216A0 (en) | 2002-09-05 | 2002-09-05 | Surfactants and lyotropic phases formed therefrom |
| PCT/AU2003/001139 WO2004022530A1 (en) | 2002-09-05 | 2003-09-04 | Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010067498A Division JP2010209072A (ja) | 2002-09-05 | 2010-03-24 | 尿素−、グリセラート−及びヒドロキシアミド−頭部形成した炭化水素鎖のリオトロピック相形成性界面活性剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005538151A true JP2005538151A (ja) | 2005-12-15 |
| JP2005538151A5 JP2005538151A5 (enExample) | 2008-07-17 |
Family
ID=27671538
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004533054A Ceased JP2005538151A (ja) | 2002-09-05 | 2003-09-04 | 尿素−、グリセラート−及びヒドロキシアミド−頭部形成した炭化水素鎖のリオトロピック相形成性界面活性剤 |
| JP2010067498A Withdrawn JP2010209072A (ja) | 2002-09-05 | 2010-03-24 | 尿素−、グリセラート−及びヒドロキシアミド−頭部形成した炭化水素鎖のリオトロピック相形成性界面活性剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010067498A Withdrawn JP2010209072A (ja) | 2002-09-05 | 2010-03-24 | 尿素−、グリセラート−及びヒドロキシアミド−頭部形成した炭化水素鎖のリオトロピック相形成性界面活性剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050249665A1 (enExample) |
| EP (1) | EP1534669A4 (enExample) |
| JP (2) | JP2005538151A (enExample) |
| KR (1) | KR100948890B1 (enExample) |
| CN (2) | CN101538200A (enExample) |
| AU (2) | AU2002951216A0 (enExample) |
| CA (1) | CA2497322A1 (enExample) |
| NO (1) | NO20051142L (enExample) |
| WO (1) | WO2004022530A1 (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007504256A (ja) * | 2003-09-01 | 2007-03-01 | メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド | 生物活性剤の送達のための組成物及び方法 |
| JP2011503050A (ja) * | 2007-11-08 | 2011-01-27 | イッサム リサーチ ディべロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム,リミテッド | スフィンゴリピドの新規合成アナログ |
| WO2021033482A1 (ja) * | 2019-08-19 | 2021-02-25 | Jsr株式会社 | 分散組成物、分散剤、異方性膜及びその製造方法、並びに異方性膜形成装置 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006043705A1 (ja) * | 2004-10-19 | 2006-04-27 | National Institute Of Advanced Industrial Scienceand Technology | Ii型キュービック液晶組成物 |
| EP2393472B1 (en) | 2008-12-05 | 2019-06-05 | NanoMed Holdings Pty Ltd | Amphiphile prodrugs |
| WO2012119838A1 (en) * | 2011-03-04 | 2012-09-13 | Unilever Nv | Self-adhesive hard surface cleaning composition |
Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3211692A (en) * | 1961-11-06 | 1965-10-12 | Gulf Oil Corp | Ethylene polymeric compositions containing substituted ureas |
| US4039576A (en) * | 1972-03-28 | 1977-08-02 | Ciba-Geigy Corporation | Process for the manufacture of alkoxylated N-methylol ureas |
| US4081386A (en) * | 1976-10-01 | 1978-03-28 | The Lubrizol Corporation | Reaction mixtures from reacting di- and triazines with sulfur-containing compounds and lubricants and fuels containing the same |
| JPS63308096A (ja) * | 1987-05-21 | 1988-12-15 | エフエムシー コーポレイション (ユーケー) リミテッド | 機能液 |
| JPH01249650A (ja) * | 1988-03-30 | 1989-10-04 | Toshiba Corp | 射出成形用バインダー組成物 |
| JPH05247488A (ja) * | 1991-12-31 | 1993-09-24 | Unilever Nv | 洗剤組成物 |
| JPH09503295A (ja) * | 1993-09-20 | 1997-03-31 | ウォーターズ コーポレーション | キラール界面活性剤及びそれらのキラール分離における使用方法 |
| JPH09324172A (ja) * | 1996-06-05 | 1997-12-16 | Sekisui Chem Co Ltd | 水分散系離型剤 |
| WO1999026584A2 (en) * | 1997-11-24 | 1999-06-03 | The Scripps Research Institute | Inhibitors of gap junction communication |
| JPH11209279A (ja) * | 1998-01-05 | 1999-08-03 | Natural Ltd As | 体重減少および肥満処置の方法 |
| WO1999064389A1 (en) * | 1998-06-09 | 1999-12-16 | Alexandros Makriyannis | Inhibitors of the anandamide transporter as analgesic agents |
| JP2001234197A (ja) * | 2000-02-24 | 2001-08-28 | Kawaken Fine Chem Co Ltd | 液体洗浄剤組成物 |
| JP2001302600A (ja) * | 2000-04-18 | 2001-10-31 | Kawaken Fine Chem Co Ltd | 脂肪酸アルカノールアミド化合物の製造法 |
| JP2002527358A (ja) * | 1998-08-31 | 2002-08-27 | グリフォン サイエンシーズ | 脂質マトリックス介助化学連結方法および膜ポリペプチドの合成 |
| JP2002539150A (ja) * | 1999-03-16 | 2002-11-19 | カプシュリース | 複合分散体の形状をした媒質、その調製方法及びその使用 |
| JP2003531930A (ja) * | 2000-04-28 | 2003-10-28 | ユニバーシティ・カレッジ・ダブリン | 両親媒性大環状誘導体およびそれらの類似体 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2813783A (en) * | 1953-05-18 | 1957-11-19 | Universal Oil Prod Co | Stabilization of organic compounds |
| GB818864A (en) * | 1956-05-15 | 1959-08-26 | Monsanto Chemicals | Process for the production of ureas |
| US3157477A (en) * | 1961-10-03 | 1964-11-17 | Standard Oil Co | Nu-acylated aminohydroxy compound as a multi-functional gasoline additive |
| US3161676A (en) * | 1962-05-21 | 1964-12-15 | Berkeley Chemical Corp | Preparation of substituted alkyl ureas |
| US3956366A (en) * | 1967-11-21 | 1976-05-11 | Pennwalt Corporation | N-monohalomonosubstituted ureas |
| US3706667A (en) * | 1970-08-03 | 1972-12-19 | Monsanto Co | Monosubstituted ureas in lubricating compositions |
| JPS5695108A (en) * | 1979-12-28 | 1981-08-01 | Kao Corp | Water-in-oil cosmetic |
| JPS56133281A (en) * | 1980-03-21 | 1981-10-19 | Kao Corp | Preparation of glyceryl ether |
| DE3239858A1 (de) * | 1982-07-06 | 1984-01-12 | Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Neue d-mannitderivate als ausgangsprodukte zur synthese von phospholipiden |
| CA1264162A (en) * | 1984-03-15 | 1990-01-02 | Manfred Breuninger | Glycerol ether phosphatides |
| DE3442145A1 (de) * | 1984-11-17 | 1986-05-22 | Weber, Nikolaus, Dr., 4400 Münster | Verfahren zur herstellung komplexer etherglycerolipide unter verwendung von pflanzlichen zellkulturen |
| EP0450527A3 (en) * | 1990-03-30 | 1991-10-30 | Kao Corporation | N-tris(hydroxymethyl)methylfatty acid amides and cosmetic compositions containing same |
| DE4420625C1 (de) * | 1994-06-14 | 1995-11-02 | Beiersdorf Ag | Wirkstoffkombination mit einem Gehalt an Glycerylalkylethern und kosmetische und dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend |
| DE19632482A1 (de) * | 1996-08-12 | 1998-02-19 | Basf Ag | Tenside |
| US6019990A (en) * | 1997-11-21 | 2000-02-01 | Natural Nutrition Ltd. As | Conjugated linoleic acid delivery system in cosmetic preparations |
| JPH11209775A (ja) * | 1998-01-22 | 1999-08-03 | Idemitsu Kosan Co Ltd | 工作機械油組成物 |
| US6251931B1 (en) * | 1998-11-24 | 2001-06-26 | The Scripps Research Institute | Inhibitors of gap junction communication |
| JP2002180086A (ja) * | 2000-12-08 | 2002-06-26 | Kawaken Fine Chem Co Ltd | 増粘剤およびそれを含む高粘度液体洗浄剤組成物 |
| EP1667656A4 (en) * | 2003-09-01 | 2011-12-28 | Mayne Pharma Int Pty Ltd | COMPOSITIONS AND METHODS OF DISTRIBUTING BIOLOGICALLY ACTIVE AGENTS |
-
2002
- 2002-09-05 AU AU2002951216A patent/AU2002951216A0/en not_active Abandoned
-
2003
- 2003-09-04 CN CNA200810188953XA patent/CN101538200A/zh active Pending
- 2003-09-04 CA CA002497322A patent/CA2497322A1/en not_active Abandoned
- 2003-09-04 KR KR1020057003886A patent/KR100948890B1/ko not_active Expired - Fee Related
- 2003-09-04 CN CNA038244373A patent/CN1694865A/zh active Pending
- 2003-09-04 JP JP2004533054A patent/JP2005538151A/ja not_active Ceased
- 2003-09-04 EP EP03793472A patent/EP1534669A4/en not_active Withdrawn
- 2003-09-04 AU AU2003257254A patent/AU2003257254B2/en not_active Ceased
- 2003-09-04 WO PCT/AU2003/001139 patent/WO2004022530A1/en not_active Ceased
-
2005
- 2005-03-03 NO NO20051142A patent/NO20051142L/no not_active Application Discontinuation
- 2005-03-04 US US11/071,113 patent/US20050249665A1/en not_active Abandoned
-
2010
- 2010-03-24 JP JP2010067498A patent/JP2010209072A/ja not_active Withdrawn
Patent Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3211692A (en) * | 1961-11-06 | 1965-10-12 | Gulf Oil Corp | Ethylene polymeric compositions containing substituted ureas |
| US4039576A (en) * | 1972-03-28 | 1977-08-02 | Ciba-Geigy Corporation | Process for the manufacture of alkoxylated N-methylol ureas |
| US4081386A (en) * | 1976-10-01 | 1978-03-28 | The Lubrizol Corporation | Reaction mixtures from reacting di- and triazines with sulfur-containing compounds and lubricants and fuels containing the same |
| JPS63308096A (ja) * | 1987-05-21 | 1988-12-15 | エフエムシー コーポレイション (ユーケー) リミテッド | 機能液 |
| JPH01249650A (ja) * | 1988-03-30 | 1989-10-04 | Toshiba Corp | 射出成形用バインダー組成物 |
| JPH05247488A (ja) * | 1991-12-31 | 1993-09-24 | Unilever Nv | 洗剤組成物 |
| JPH09503295A (ja) * | 1993-09-20 | 1997-03-31 | ウォーターズ コーポレーション | キラール界面活性剤及びそれらのキラール分離における使用方法 |
| JPH09324172A (ja) * | 1996-06-05 | 1997-12-16 | Sekisui Chem Co Ltd | 水分散系離型剤 |
| WO1999026584A2 (en) * | 1997-11-24 | 1999-06-03 | The Scripps Research Institute | Inhibitors of gap junction communication |
| JPH11209279A (ja) * | 1998-01-05 | 1999-08-03 | Natural Ltd As | 体重減少および肥満処置の方法 |
| WO1999064389A1 (en) * | 1998-06-09 | 1999-12-16 | Alexandros Makriyannis | Inhibitors of the anandamide transporter as analgesic agents |
| JP2002527358A (ja) * | 1998-08-31 | 2002-08-27 | グリフォン サイエンシーズ | 脂質マトリックス介助化学連結方法および膜ポリペプチドの合成 |
| JP2002539150A (ja) * | 1999-03-16 | 2002-11-19 | カプシュリース | 複合分散体の形状をした媒質、その調製方法及びその使用 |
| JP2001234197A (ja) * | 2000-02-24 | 2001-08-28 | Kawaken Fine Chem Co Ltd | 液体洗浄剤組成物 |
| JP2001302600A (ja) * | 2000-04-18 | 2001-10-31 | Kawaken Fine Chem Co Ltd | 脂肪酸アルカノールアミド化合物の製造法 |
| JP2003531930A (ja) * | 2000-04-28 | 2003-10-28 | ユニバーシティ・カレッジ・ダブリン | 両親媒性大環状誘導体およびそれらの類似体 |
Non-Patent Citations (3)
| Title |
|---|
| JPN6009050015, Journal of Medicinal Chemistry, 1999, 42(11), p.1975−1981 * |
| JPN6009050017, Proceedings of the National Academy of Sciences of the United States of America, 1998, 95(8), p.4102−4107 * |
| JPN6009050019, Tetrahedron Letters, 1996, 37(44), p.7871−7874 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007504256A (ja) * | 2003-09-01 | 2007-03-01 | メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド | 生物活性剤の送達のための組成物及び方法 |
| JP2011503050A (ja) * | 2007-11-08 | 2011-01-27 | イッサム リサーチ ディべロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム,リミテッド | スフィンゴリピドの新規合成アナログ |
| WO2021033482A1 (ja) * | 2019-08-19 | 2021-02-25 | Jsr株式会社 | 分散組成物、分散剤、異方性膜及びその製造方法、並びに異方性膜形成装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101538200A (zh) | 2009-09-23 |
| US20050249665A1 (en) | 2005-11-10 |
| EP1534669A4 (en) | 2007-03-14 |
| EP1534669A1 (en) | 2005-06-01 |
| CN1694865A (zh) | 2005-11-09 |
| AU2003257254A1 (en) | 2004-03-29 |
| WO2004022530A1 (en) | 2004-03-18 |
| KR20050088990A (ko) | 2005-09-07 |
| JP2010209072A (ja) | 2010-09-24 |
| NO20051142L (no) | 2005-04-14 |
| CA2497322A1 (en) | 2004-03-18 |
| KR100948890B1 (ko) | 2010-03-24 |
| AU2003257254B2 (en) | 2009-02-19 |
| AU2002951216A0 (en) | 2002-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Eccleston | Functions of mixed emulsifiers and emulsifying waxes in dermatological lotions and creams | |
| Makai et al. | Structure and drug release of lamellar liquid crystals containing glycerol | |
| Garti et al. | Some characteristics of sugar ester nonionic microemulsions in view of possible food applications | |
| Nutter et al. | Designing and characterizing multicomponent, plant-based bigels of rice bran wax, gums, and monoglycerides | |
| JP2010209072A (ja) | 尿素−、グリセラート−及びヒドロキシアミド−頭部形成した炭化水素鎖のリオトロピック相形成性界面活性剤 | |
| Liu et al. | A novel strategy to fabricate stable oil foams with sucrose ester surfactant | |
| Fong et al. | Micellar Fd3m cubosomes from monoolein–long chain unsaturated fatty acid mixtures: Stability on temperature and pH response | |
| JPH10500675A (ja) | マイクロエマルションを基礎にしたゲルから由来する医薬組成物、その製造方法および新規なマイクロエマルションを基礎にしたゲル | |
| Li et al. | Effect of Crystallization State on the Gel Properties of Oleogels Based on β-sitosterol | |
| Gorantla et al. | Exploring the affluent potential of glyceryl mono oleate–myristol liquid crystal nanoparticles mediated localized topical delivery of Tofacitinib: Study of systematic QbD, skin deposition and dermal pharmacokinetics assessment | |
| Macierzanka et al. | Effect of crystalline emulsifier composition on structural transformations of water-in-oil emulsions: Emulsification and quiescent conditions | |
| Brito et al. | Morphology, thermal behavior, and stability of self-assembled supramolecular tubules from lysine-based surfactants | |
| Zhang et al. | Fabrication and characterization of fat crystal-stabilized W/O high internal phase Pickering emulsions (HIPPEs) as a low-fat alternative margarine | |
| de Araujo et al. | Lyotropic liquid crystal mesophases as transdermal delivery systems for lipophilic drugs: A comparative study | |
| da Silva et al. | Modifying sucrose esters oleogels properties using different structuration routes | |
| Keskin Uslu et al. | Preparation and characterization of oleogels and emulgels with glycerol monooleate–cholesterol mixtures | |
| Percebom et al. | Phase behavior controlled by the addition of long-chain n-alcohols in systems of cationic surfactant/anionic polyion complex salts and water | |
| Prodromidis et al. | Effect of tween 20 on structure, phase-transition behavior and mechanical properties of monoglyceride oleogels | |
| Chen et al. | Bovine serum albumin-liposome stabilized high oil-phase emulsion: Effect of liposome ratio on interface properties and stability | |
| Junginger | Ointments and creams as colloidal drug delivery systems | |
| Savelli et al. | Effects of tail alkyl chain length (n), head group structure and junction (Z) on amphiphilic properties of 1-ZRd, l-xylitol compounds (R= CnH2n+ 1) | |
| Gurfinkel et al. | Interactions of surfactants in nonionic/anionic reverse hexagonal mesophases and solubilization of α-chymotrypsinogen A | |
| Wagner et al. | Dual functionality of diacylglycerols in water-in-oil emulsion gel systems | |
| HK1134281A (en) | Urea-, glycerate-and, hydroxyamide-headed hydrocarbon chain lytotropic phases forming surfactants | |
| Junginger | Pharmaceutical emulsions and creams |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060314 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20060524 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20060524 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080530 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090120 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090417 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090424 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090519 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090526 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090619 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090626 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090715 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090928 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091225 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100107 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100122 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100129 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100301 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100308 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100324 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100629 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100929 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20101025 |
|
| A045 | Written measure of dismissal of application [lapsed due to lack of payment] |
Free format text: JAPANESE INTERMEDIATE CODE: A045 Effective date: 20110217 |